District of New Jersey Federal Judge Tosses 95 Plavix Cases

District of New Jersey Federal Judge Tosses 95 Plavix Cases

Introduction

U.S. District Judge Freda L. Wolfson dismissed 95 Plavix lawsuits against Bristol-Myers Squibb and Sanofi-Aventis as the patients involved in the MDL failed to respond to the court orders. It remains unclear whether the patients will represent themselves or retain new counsel after the attorneys withdraw the case.

Plavix is an oral antiplatelet prescribed to reduce the risk of a future stroke or heart attack. Lawsuits against the drug maker claim adverse effects like gastrointestinal bleeding, and severe bleeding even with ordinary wounds. Similar cases are consolidated as part of a multidistrict litigation MDL No. 2418 (In Re: Plavix Marketing, Sales Practices, and Product Liability Litigation (No. II)) in the District of New Jersey.